期刊文献+

CYP19基因多态性与阿尔茨海默病遗传易感性的相关性研究 被引量:1

Relationship between CYP19 gene polymorphism and Alzheimer's disease
原文传递
导出
摘要 目的探讨CYP19基因的多态性与阿尔茨海默病(AD)的关系。方法利用聚合酶链式反应一限制性片段长度多态性(PCR—RFLP)技术分析了102例AD患者与121名正常健康成人CYP19基因胍I位点等位基因分布频率,比较基因型在AD患者与正常人之间的分布差异。结果(1)CYP19等位基因频率分布:AD组m1、m2分别为66.2%、33.8%,正常对照组分别为81.0%、19.0%,两组比较差异有统计学意义(x2=12.696,P〈0.05)。(2)CYP19基因MfeI位点基因型分布频率:AD组ml/ml、ml/m2、m2/m2分布与正常对照组比较差异有统计学意义(44.1%、44.1%、11.8%;65.3%、31.4%、3.3%;x2=12.384,P〈0.05)。结论CYP19基因多态性与AD的遗传易感性有相关性。 Objective To investigate the relationship between CYP19 gene polymorphism and Alzheimer disease. Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to analyze the allele frequency distribution at the Mfe I site of CYP19 gene in 102 patients with Alzheimer disease and 121 healthy control subjects. Results The frequencies of CYPI9 ml and m2 alleles showed significant differences between the patient group and the control group (66.2% vs 81.0% and 33.8% vs 19.0%, respectively, X2=12.696, P〈0.05). In patients with Alzheimer disease, the frequencies ofml/ml, ml/m2, m2/m2 genotypes ofCYP19 gene were 44.1%, 44.1%, and 11.8%, respectively, showing significant differences from the frequencies in the control subjects (65.3%, 31.4%, and 3.3%, respectively, X2=12.384, P〈0.05). Conclusion CYP19 gene polymorphism at the Mfe I site is associated with the genetic susceptibility to Alzheimer disease.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第1期2-4,共3页 Chinese Journal of Neuromedicine
关键词 阿尔茨海默病: CYP19 基因多态性 Alzheimer' s disease CYP19 Gene polymorphism
  • 相关文献

参考文献9

  • 1欧阳晓春,刘振华,吴多斌,谭盛.N-乙酰基转移酶基因多态性与老年性痴呆的关系[J].中国临床康复,2005,9(41):20-22. 被引量:2
  • 2Trainor BC, Kyomen HH, Marler CA. Estrogenic encounters :How interactions between aromatase and environment modulate aggression[J]. Frontiers Neuroendoci, 2006, 27(2): 170-179.
  • 3Oteiza PI. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation[J]. Arch Biochem Biophys, 1994, 308: 374-379.
  • 4Hardad N, Yamada K, Saito K, et al. Structrual characterization of the human estrogen syntheatse (aromatase) gene [J]. Biochem Biophys Res Commun, 1990, 166(1): 365.
  • 5Katsumi T, Satoshi N, Yutakaas S. Identification and characterizatioon of transcriptional regulatory elements of the human aromatase cytochrome P450 gene [J]. J Steroid Biochem Molec Biol, 1996, 56(1): 151.
  • 6Kilgore MW, Means GD, Mendelson CR, et al. Altermative promotion of aromatase cytochrome P450 expression in human fetal tissues[J]. Mol Cell Endocrinol, 1992, 83: 9.
  • 7沈凌,李占魁.脑芳香化酶的表达特点及其生物学意义[J].实用儿科临床杂志,2006,21(22):1586-1588. 被引量:6
  • 8Hiltunen M, Mannermaa A, Thompson D, et al. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland[J]. Neurology, 2001, 57: 1663-1668.
  • 9Huang R , Poduslo SE. CYP19 haplotypes increase risk for Alzheimer's disease[J]. J Med Genet, 2006, 43: 42.

二级参考文献32

  • 1Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9(1):29-42
  • 2Hickman D,Pope J,Patil SD, et al.Expression of arylamine N-acetyltransferase in human intestine. Gut 1998;42(3):402-9
  • 3Anderson AJ, Su JH, Cotman CW.DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay.J Neurosci 1996; 16(5): 1710-9
  • 4Su JH, Deng G, Cotman CW.Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain.Brain Res 1997;774(1-2):193-9
  • 5Lin HJ,Han CY,Hardy S,et al.slow acetylator mutations in the human polymorphic N-acetytransferase gene in 786 Asians,blacks, Hispanics,and Whites:Application to metabolicepidemiology.Am J Hum Genet 1993;52(4):827-34
  • 6Daly AK,Cholerton S,Gregory W,et al.Metabolic polymorphisms.Pharmac her 1993;57(2-3):129-60
  • 7Ogawa M.Biochemical,molecular genetic and ecogenetic studies of polymorphic arylamine N-acetyltransferase (NAT2) in the brain. Fukuoka Igaku Zasshi 1999;90(4):118-31
  • 8Rocha L,Garcia C, de Mendonca A, et al.N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer′s disease.Pharmacogenetics 1999;9(1): 9-15
  • 9Johnson N,Bell P,Jonovska V,et al.NAT gene polymorphisms and susceptibility to Alzheimer's disease:identification of a novel NAT1 allelic variant.BMC Med Genet 2004;5:6
  • 10Nicholl DJ, Bennett P, Hiller L,et al.A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism.Neurology 1999;53(7):1415-21

共引文献6

同被引文献12

  • 1Rhein V,Song X,Wiesner A,et al.Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice[J].Proc Natl Acad Sci U S A,2009,106(47):20057-2062.
  • 2Butterfield DA,Lange ML.Multifunctional roles of enolase in Alzheimer's disease brain:beyond altered glucose metabolism[J].J Neurochem,2009,11(4):915-933.
  • 3Gozal YM,Duong DM,Gearing M,et al.Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease[J].J Proteome Res,2009,8(11):5069-5079.
  • 4Chen W,Ji J,Ru B,et al.Proteomic analysis of corticobasal degeneration:a case study of corticobasal degeneration at the proteome level[J].J Neuropsychiatry Clin Neurosci,2005,17(3):364-371.
  • 5Pfaendtner J,De La,Cruz EM.Actin filament remodeling by actin depolymerization factor/cofilin[J].Proc Natl Acad Sci USA,2010,107(16):239-254.
  • 6David Muyllaert,Dick Terwel.Anna kremer neurodegeneration and neuroinflammation in cdk5/p25-inducible mice:a model for hippocampal sclerosis and neocortical degeneration[J].Am J Pathol,2008,172(2):470-485.
  • 7Radyuk SN,Michalak K,Klichko VI,et al.Peroxiredoxin 5 confers protection against oxidative stress and apoptosis and also promotes longevity in Drosophila[J].Biochem J,2009,419(2):437-445.
  • 8Kronenberg G,Harms C,Sobol RW,et al.Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase[J].J Neurosci,2008,28(28):7219-730.
  • 9Li Z,Chen-Roetling J,Regan RF.Increasing expression of H-or L-ferritin protects cortical astrocytes from hemin toxicity[J].Free Radic Res,2009,43(6):613-621.
  • 10Sultana R,Boyd-Kimball D,Poon HF,et al.Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum:an approach to understand pathological and biochemical alterations in AD[J].Neurobiol Aging,2006,27(11):1564-1576.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部